Go Pro
OTCMKTS:VASO

Vaso Q3 2025 Earnings Report

Vaso logo
$0.29 0.00 (-1.61%)
As of 02:03 PM Eastern

Vaso EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Vaso Revenue Results

Actual Revenue
$22.66 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vaso Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Vaso Earnings Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
See More Vaso Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vaso? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vaso and other key companies, straight to your email.

About Vaso

Vaso (OTCMKTS:VASO) is a healthcare technology company that develops, markets and distributes medical devices, diagnostic products and healthcare information technology solutions. Its activities are organized around medical technology, diagnostic products and healthcare services for hospitals, physicians and other healthcare providers.

The company’s offerings have included diagnostic imaging equipment and related services, proprietary medical devices and software designed to support clinical workflows, data management and patient care. Vaso has also operated as a distributor of healthcare equipment, including products from GE HealthCare, serving selected markets in the United States.

Vaso Corporation, formerly known as Vasomedical, has historically focused on combining medical-device development with healthcare product distribution and technology services. Its business has primarily served customers in the United States, with operations and partnerships directed toward the hospital and diagnostic-imaging markets.

View Vaso Profile